What are the reasons behind the recall of Bharat Biotech's typhoid vaccine batch

The recall of Bharat Biotech's typhoid vaccine batch was due to the following reasons:

1. Substandard manufacturing conditions: The company found that the manufacturing process of the vaccine batch did not meet the required standards and quality control measures.
2. Inadequate potency: The vaccine batch was found to have a lower potency level than what is considered effective in providing immunity against typhoid.
3. Possible reduced efficacy: As a result of the lower potency, the vaccine batch may not provide adequate protection against typhoid, potentially compromising the health of individuals who received the vaccine.
4. Patient safety concerns: The recall was initiated to ensure patient safety and prevent any potential risks associated with the use of a substandard and less effective vaccine.
5. Compliance with regulatory requirements: Bharat Biotech aims to comply with regulatory guidelines and maintain the quality of its products, hence the recall to rectify the issue and prevent further distribution of the defective vaccine.

It is important to note that the specific details and circumstances surrounding the recall may vary, so consulting official sources or contacting Bharat Biotech directly for the most accurate and up-to-date information is recommended.